Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-12, with 36 holding rows worth $594,940,000.

Accession
0001140361-18-006476
Filed
2018-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 36 entries on the cover page, a total value of $594,940,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $594,940,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM1,079,842$61,627,000thousands by filing date
BAXTER INTL INC071813109COM694,438$44,888,000thousands by filing date
Boston Scientific Corporation101137107COM1,700,880$42,165,000thousands by filing date
REVVITY INC714046109COM440,808$32,232,000thousands by filing date
Merck & Co.,Inc.58933Y105COM558,500$31,427,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR896,771$31,118,000thousands by filing date
Elevance Health, Inc.036752103COM121,310$27,296,000thousands by filing date
Gilead Sciences,Inc.375558103COM357,890$25,639,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW506,630$24,247,000thousands by filing date
Bristol-Myers Squibb Company110122108COM385,006$23,593,000thousands by filing date
BIO RAD LABS INC090572207CL A95,040$22,683,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock249,540$21,750,000thousands by filing date
BIOGEN INC COM09062X103Stock65,800$20,962,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,188,553$17,816,000thousands by filing date
NUVASIVE INC670704105COM260,200$15,219,000thousands by filing date
CIGNA CORPORATION125509109COM73,170$14,860,000thousands by filing date
Eli Lilly and Company532457108COM153,414$12,957,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW80,000$12,761,000thousands by filing date
PATTERSON COS INC703395103COM303,132$10,952,000thousands by filing date
MCKESSON CORP COM58155Q103Stock67,315$10,498,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO67,075$10,405,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM150,992$10,267,000thousands by filing date
ALLERGAN PLCG0177J108SHS62,600$10,240,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR273,312$9,694,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK837,192$8,271,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock465,621$7,059,000thousands by filing date
DAVITA INC COM23918K108Stock86,680$6,263,000thousands by filing date
STERICYCLE INC858912108COM81,800$5,562,000thousands by filing date
MYLAN NVN59465109SHS EURO131,361$5,558,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM275,024$3,837,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock62,100$3,124,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM52,500$2,700,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock50,000$2,434,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM43,400$1,984,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW52,173$1,658,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock9,400$1,194,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-006476this filing2018-02-12acceptance time not in the bulk data set